National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
imatinib mesylate (ih-MAH-tih-nib MEH-zih-layt)

 A drug used to treat different types of leukemia and other cancers of the blood, gastrointestinal stromal tumors, skin tumors called dermatofibrosarcoma protuberans, and a rare condition called systemic mastocytosis. It is also being studied in the treatment of other types of cancer. Imatinib mesylate blocks the protein made by the bcr/abl oncogene. It is a type of tyrosine kinase inhibitor. Also called Gleevec and STI571.

Previous Definitions:IM, IM-862, imagery, imaging, imaging procedure
Next Definitions:imexon, imipenem, imiquimod, immature teratoma, IMMU-106